| Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer I Garcia-Murillas, G Schiavon, B Weigelt, C Ng, S Hrebien, RJ Cutts, ... Science translational medicine 7 (302), 302ra133-302ra133, 2015 | 1193 | 2015 |
| Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma L De Mattos-Arruda, R Mayor, CKY Ng, B Weigelt, F Martínez-Ricarte, ... Nature communications 6 (1), 8839, 2015 | 744 | 2015 |
| Genomic characterization of metastatic breast cancers F Bertucci, CKY Ng, A Patsouris, N Droin, S Piscuoglio, N Carbuccia, ... Nature 569 (7757), 560-564, 2019 | 559 | 2019 |
| A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) J Mateo, D Chakravarty, R Dienstmann, S Jezdic, A Gonzalez-Perez, ... Annals of Oncology 29 (9), 1895-1902, 2018 | 535 | 2018 |
| Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer HL Gomez, DC Doval, MA Chavez, PCS Ang, Z Aziz, S Nag, C Ng, ... Journal of Clinical Oncology 26 (18), 2999-3005, 2008 | 425 | 2008 |
| Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis RF Schwarz, CKY Ng, SL Cooke, S Newman, J Temple, AM Piskorz, ... PLoS medicine 12 (2), e1001789, 2015 | 395 | 2015 |
| Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle L De Mattos-Arruda, B Weigelt, J Cortes, HH Won, CKY Ng, P Nuciforo, ... Annals of oncology 25 (9), 1729-1735, 2014 | 394 | 2014 |
| Breast cancer intra-tumor heterogeneity LG Martelotto, CKY Ng, S Piscuoglio, B Weigelt, JS Reis-Filho Breast Cancer Research 16, 1-11, 2014 | 370 | 2014 |
| Organoid models of human liver cancers derived from tumor needle biopsies S Nuciforo, I Fofana, MS Matter, T Blumer, D Calabrese, T Boldanova, ... Cell reports 24 (5), 1363-1376, 2018 | 360 | 2018 |
| Progression from ductal carcinoma in situ to invasive breast cancer: revisited CF Cowell, B Weigelt, RA Sakr, CKY Ng, J Hicks, TA King, JS Reis-Filho Molecular oncology 7 (5), 859-869, 2013 | 356 | 2013 |
| Chromosomal instability determines taxane response C Swanton, B Nicke, M Schuett, AC Eklund, C Ng, Q Li, T Hardcastle, ... Proceedings of the National Academy of Sciences 106 (21), 8671-8676, 2009 | 311 | 2009 |
| SF3B1 mutations constitute a novel therapeutic target in breast cancer SL Maguire, A Leonidou, P Wai, C Marchiò, CKY Ng, A Sapino, ... The Journal of pathology 235 (4), 571-580, 2015 | 243 | 2015 |
| Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer B Weigelt, I Comino-Méndez, I de Bruijn, L Tian, JL Meisel, ... Clinical Cancer Research 23 (21), 6708-6720, 2017 | 240 | 2017 |
| Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ... Nature genetics 46 (11), 1166-1169, 2014 | 221 | 2014 |
| Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma SL Cooke, CKY Ng, N Melnyk, MJ Garcia, T Hardcastle, J Temple, ... Oncogene 29 (35), 4905-4913, 2010 | 190 | 2010 |
| The protein histidine phosphatase LHPP is a tumour suppressor SK Hindupur, M Colombi, SR Fuhs, MS Matter, Y Guri, K Adam, M Cornu, ... Nature 555 (7698), 678-682, 2018 | 184 | 2018 |
| Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas AM Schultheis, CKY Ng, MR De Filippo, S Piscuoglio, GS Macedo, ... Journal of the National Cancer Institute 108 (6), djv427, 2016 | 181 | 2016 |
| A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations S Kohsaka, N Shukla, N Ameur, T Ito, CKY Ng, L Wang, D Lim, ... Nature genetics 46 (6), 595-600, 2014 | 172 | 2014 |
| The genomic landscape of male breast cancers S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ... Clinical Cancer Research 22 (16), 4045-4056, 2016 | 152 | 2016 |
| Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification CKY Ng, LG Martelotto, A Gauthier, HC Wen, S Piscuoglio, RS Lim, ... Genome biology 16, 1-21, 2015 | 152 | 2015 |
